Sequence Type 5 (ST5) as a Possible Predictor of Bacterial Persistence in Adult Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia Treated with Vancomycin
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sequence Type 5 (ST5) as a Possible Predictor of Bacterial Persistence in Adult Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia Treated with Vancomycin
Authors
Keywords
-
Journal
Microbiology Spectrum
Volume 10, Issue 5, Pages -
Publisher
American Society for Microbiology
Online
2022-09-12
DOI
10.1128/spectrum.01348-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
- (2020) Michael J Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
- (2020) Michael J Rybak et al. CLINICAL INFECTIOUS DISEASES
- A Functional ClpXP Protease is Required for Induction of the Accessory Toxin Genes, tst, sed, and sec
- (2020) Jenny Schelin et al. Toxins
- Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society
- (2020) Na He et al. CLINICAL INFECTIOUS DISEASES
- Decreasing methicillin-resistant Staphylococcus aureus (MRSA) infections is attributable to the disappearance of predominant MRSA ST239 clones, Shanghai, 2008–2017
- (2019) Yingxin Dai et al. Emerging Microbes & Infections
- The Emperor’s New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE)
- (2019) Thomas P Lodise et al. CLINICAL INFECTIOUS DISEASES
- Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates
- (2019) Alberto Antonelli et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Predominance of ST5-II-t311 clone among healthcare-associated methicillin-resistant Staphylococcus aureus isolates recovered from Zhejiang, China
- (2018) Dandan Wu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Deaths From Pneumonia—New York City, 1999–2015
- (2018) Evette Cordoba et al. Open Forum Infectious Diseases
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) CLINICAL INFECTIOUS DISEASES
- Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Christopher Troeger et al. LANCET INFECTIOUS DISEASES
- Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Daniel Dicker et al. LANCET
- Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter?
- (2016) Kimberly C. Claeys et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical and Microbiologic Analysis of the Risk Factors for Mortality in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bacteremia
- (2015) Yong Pil Chong et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Earlyagractivation correlates with vancomycin treatment failure in multi-clonotype MRSA endovascular infections
- (2015) Wessam Abdelhady et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Morbidity and mortality of pneumonia in adults in six Latin American countries
- (2013) Alfonso Rosado Buzzo et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Persistent Staphylococcus aureus Bacteremia
- (2013) Yong Pil Chong et al. MEDICINE
- Methicillin-Resistant Staphylococcus aureus (MRSA) Staphylococcal Cassette Chromosome mec Genotype Effects Outcomes of Patients With Healthcare-Associated MRSA Bacteremia Independently of Vancomycin Minimum Inhibitory Concentration
- (2012) S.-Y. Chen et al. CLINICAL INFECTIOUS DISEASES
- Predictors of Mortality in Staphylococcus aureus Bacteremia
- (2012) S. J. van Hal et al. CLINICAL MICROBIOLOGY REVIEWS
- Phenotypic and Genotypic Characteristics of Persistent Methicillin‐ResistantStaphylococcus aureusBacteremia In Vitro and in an Experimental Endocarditis Model
- (2008) Yan Q. Xiong et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started